SRS Capital Advisors »

Kyverna Therapeutics shares owned by SRS Capital Advisors

Quarter-by-quarter ownership of Kyverna Therapeutics (KYTX) shares owned by SRS Capital Advisors from 13F filings

Historical chart of SRS Capital Advisors investment in Kyverna Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Kyverna Therapeutics held by SRS Capital Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Kyverna Therapeutics by SRS Capital Advisors

Quarter filed Position value Share count Share price at filing
2025-09-30 $66 11 6.00

More positions owned by SRS Capital Advisors

Vanguard Index Fds Growth Etf (VOO)
Ishares Tr Ishs 1-5yr Invs (OEF)
First Tr Exchange-traded Wtr Etf (FDL)
American Centy Etf Tr Us Large Cap Vlu (KORP)
Dimensional Etf Trust Intl Core Equity (DFAI)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Apple (AAPL)
Schwab Strategic Tr Us Tips Etf (SCHB)
Microsoft Corporation (MSFT)
First Tr Exchng Traded Fd Vi Smith Opport Fxd (FIXD)
First Tr Exchange Traded Risng Divd Achiv (FXN)
NVIDIA Corporation (NVDA)
First Tr Exch Traded Fd Iii Pfd Secs Inc Etf (FPE)
Spdr S&p 500 Etf Tr Tr Unit
Vanguard Tax-managed Fds Van Ftse Dev Mkt (VEA)

View all positions for SRS Capital Advisors

Top funds holding Kyverna Therapeutics

Vida Ventures Advisors
Gilead Sciences
Bain Capital Life Sciences Investors
Vanguard Group
Insight Holdings
Franklin Resources
Mbb Public Markets I
Catalio Capital Management
Millennium Management
BlackRock
Kera Capital Partners
Peapod Lane Capital
Geode Capital Management
Woodline Partners
Susquehanna International

View all funds holding Kyverna Therapeutics